Functional Technologies Reports Second Quarter 2012 Financial Results
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/30/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the second quarter ended February 29, 2012 ("Q2/12"). Amounts, unless specified otherwise, are expressed in Canadian dollars. The Company's Q2/12 consolidated financial statements have been prepared in accordance with International Financial Reporting Standards, reporting standards by which the Company has transitioned to from Canadian Generally Accepted Accounting Principles.
"Functional Technologies' proprietary acrylamide-preventing (AP) and hydrogen sulphide (H2S)-preventing yeast platforms continue to drive significant interest and validation with major food producers and commercial winemakers. As the Company continues to accomplish substantial achievements in building technical and commercial value for these core programs, we have also made significant progress in divesting non-core assets so as to reduce non-essential spending," said Mr. Christopher Morris, Functional Technologies' acting CEO. "Collectively, the strategies we have implemented company-wide are expected to provide opportunities to achieve significant benefits and milestones in the coming quarters."
Operating Highlights
During Q2/12, the Company:
Financial Results
The Company incurred a net loss of $4.6 million during Q2/12, compared to a net loss of $1.0 million for the three months ended February 28, 2011 ("Q2/11"), representing an increase of $3.6 million that is primarily the result of the loss of $3.4 million due to a non-cash impairment of the carrying value of Phyterra Bio Inc. and Maritime Pulse Drying Inc.
Operating expenses, excluding stock-based compensation expenses, for Q2/12 were $1.1 million, compared to $1.0 million in Q2/11. The slight increase in operating expenses was attributed primarily to increases in legal expenses as well as salaries and wages associated in part with elevated business development and marketing activities. Government funding in Q2/12 decreased by $0.3 million from $0.5 million in Q2/11 due to reduced R&D activities conducted by the Company's subsidiary Phyterra Bio Inc.
Liquidity and Outstanding Share Capital
As at February 29, 2012, the Company had cash and short-term investments of $1.9 million compared to $4.2 million as at August 31, 2011. As at February 29, 2012, the Company had working capital of $1.7 million compared to $3.9 million as at August 31, 2011.
As at April 27, 2012, Functional Technologies had 49,396,895 common shares issued and outstanding.
Additional Information
This news release should be read in conjunction with the Company's consolidated financial statements for the quarter ended February 29, 2012 and the notes thereto, together with the MD&A for the corresponding period, which are available on the Company's website and on SEDAR at .
About Functional Technologies Corp.
Functional Technologies develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries. The Company's platform improves the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by the World Health Organization as probable human carcinogens. Functional Technologies' lead technologies include yeasts that prevent and reduce the formation of the foul-smelling hydrogen sulphide (H2S) and the carcinogens acrylamide and ethyl carbamate (more commonly known as urethane), by-products of food and beverage processing. These contaminants are found in many commonly consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. For more information, please visit our website at .
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Contacts:
Functional Technologies Corp.
Connie Chen, PhD
VP, Corporate Development and Communications
+1.647.282.5038
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.04.2012 - 23:30 Uhr
Sprache: Deutsch
News-ID 140843
Anzahl Zeichen: 0
contact information:
Town:
VANCOUVER, BRITISH COLUMBIA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 228 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Functional Technologies Reports Second Quarter 2012 Financial Results"
steht unter der journalistisch-redaktionellen Verantwortung von
Functional Technologies Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
